August 22, 2017 1:22 PM ET

Biotechnology

Company Overview of Juno Therapeutics, Inc.

Executive Profile

Marc Tessler-Lavigne Ph.D.

Scientific Advisor, Juno Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
57$361,565

Background

Dr. Marc Tessler-Lavigne, Ph.D. is the Founder of Denali Therapeutics Inc. and serves as its Chairman of The Board. Dr. Tessler-Lavigne has been the President of The Rockefeller University since 2011, where Dr. Tessler-Lavigne serves as a professor and head of the laboratory of brain development and repair. He is a Co-founder of Evotec (US), Inc. His laboratory investigates how neural circuits in the brain form during embryonic development. It also studies nerve cell ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Director
Director
Founder and Chairman of The Board
2011-Present
Director

Education

Post-Doctoral Training
Columbia University
Bachelor's Degree
McGill University
Bachelor's Degree
University of Oxford
PhD 1987
University College London
Post-Doctoral Training
University College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$12,000
Unexercisable Options$12,000
Total Number of Options$24,000

Total Compensation

Total Annual Cash Compensation$60,183
Total Calculated Compensation$361,565
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.